论文部分内容阅读
目的 探讨阿奇霉素联合硫酸特布他林气雾剂雾化吸人治疗儿童支原体肺炎的临床疗效.方法 将92例支原体肺炎患儿采用随机数字表法分为两组,各46例.观察组给予阿奇霉素联合硫酸特布他林气雾剂雾化吸入治疗,对照组给予常规治疗,比较两组临床疗效、症状改善时间及不良反应发生率.结果 观察组总有效率显著高于对照组(P＜0.01),不良反应发生率显著低于对照组(P＜0.05).观察组退热、咳嗽消失、胸片恢复正常、啰音消失时间均显著短于对照组(P＜0.01).结论 阿奇霉素联合硫酸特布他林气雾剂雾化吸人治疗支原体肺炎患儿效果良好,可显著缩短患儿症状改善时间,安全性高,值得推广应用.“,”Objective To investigate the clinical effect of azithromycin combined with Terbutaline Sulfate Aerosol through nebulization inhalation in children with mycoplasma pneumonia. Methods 92 cases of mycoplasma pneumonia were randomly divided into two groups, 46 cases in each group. The observation group was treated with azithromycin combined with Terbutaline Sulfate Aerosol through nebulization inhalation, the control group received routine treatment, compare the clinical effect,symptom improvement time and adverse reaction rate between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group (P＜0. 01),the incidence of adverse reactions in the observation group was significantly lower than that in the control group (P＜0.05). The time of fever and cough disappeared, chest X-ray returned to normal, rale extinction time in the observation group were significantly shorter than those in the control group (P＜0.01). Conclusion Azithromycin combined with Terbutaline Sulfate Aerosol through nebulization inhalation in children with mycoplasma pneumonia have better clinical effect,it can significantly shorten the symptom improvement time, with higher safety, and it is worthy of clinical promotion.